DRAK2 Antikörper (C-Term)
Kurzübersicht für DRAK2 Antikörper (C-Term) (ABIN7482649)
Target
Alle DRAK2 (STK17B) Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
-
-
Bindungsspezifität
- C-Term
-
Sequenz
- SSQTQDHSVR SSEDKTSKSS CNGTCGDRED KENIPEDSSM VSKRFRFDDS
-
Homologie
- Dog: 93%, Guinea Pig: 92%, Human: 100%, Rat: 93%
-
Produktmerkmale
- This is a rabbit polyclonal antibody against STK17B. It was validated on Western Blot.
-
Immunogen
- The immunogen is a synthetic peptide directed towards the C-terminal region of Human STK17B
-
-
-
-
Applikationshinweise
- Optimal working dilution should be determined by the investigator.
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Liquid
-
Buffer
- Liquid. Purified antibody supplied in 1x PBS buffer with 0.09 % (w/v) sodium azide and 2 % sucrose.
-
Konservierungsmittel
- Sodium azide
-
Vorsichtsmaßnahmen
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Lagerung
- -20 °C
-
Informationen zur Lagerung
- For short term use, store at 2-8°C up to 1 week. For long term storage, store at -20°C in small aliquots to prevent freeze-thaw cycles.
-
-
- DRAK2 (STK17B) (serine/threonine Kinase 17b (STK17B))
-
Andere Bezeichnung
- STK17B
-
Hintergrund
-
The function of this protein remains unknown.
Alias Symbols: DRAK2
Protein Interaction Partner: UBC, RPS24, APP, CHP1, STK17B,
Protein Size: 372 -
Gen-ID
- 9262
-
NCBI Accession
- NM_004226, NP_004217
-
UniProt
- Q53QE7
Target
-